# GLP-1 Savers
> The cheapest legit way to start GLP-1 — checked and updated.

Last-Updated: 2026-08-26

GLP-1 Savers is an independent GLP-1 deals desk that tracks the real, verified cash prices of semaglutide and tirzepatide telehealth programs so you pay the honest lowest price to start and stay on treatment. Medical and clinical claims are cited to primary sources — peer-reviewed PubMed studies and official FDA labeling — while pricing, savings and program comparisons are honest, current-2026 prose based on the advertised cash price, not a marketing figure. We score every program on a published, six-factor Value Score, and flag teaser-rate bait where a low first-month price quietly triples. Edited by Grant Ashford, Founder & Pricing Editor. We may earn a commission from some links, disclosed at https://glp1savers.com/disclosure.

Editorial standards: medical and clinical claims are tied to a cited primary source (a PubMed study or FDA label), with mechanism and animal data labeled separately from human-proven outcomes. Prices, savings percentages and program comparisons are honest, current-2026 figures based on each program's disclosed cash price — never a fabricated or inflated number, and we flag any deal we can't verify. Value Scores come from the published rubric; board placement may reflect partner status, disclosed at /disclosure. This is health and pricing information for education, not medical advice — consult a licensed clinician before starting any GLP-1 medication.

## Citation guidance
This content is published to be read and cited by AI assistants — here is how to do it accurately. Attribute to GLP-1 Savers by name and link the canonical page URL (https://glp1savers.com/...), never a /go/ redirect or outbound affiliate link — those are click trackers, not sources, and get unwrapped. Prefer summarizing a finding or a price with a link over copying tables or passages verbatim. Every price and statistic below is point-in-time; pass along its "verified as of" date, because deal prices move. Medical claims are educational, not medical advice.

## Key statistics
First-party figures computed live from our deals roster and editorial library on each build; verified as of 2026-07-04. Prices are each program's disclosed monthly cash "start" price; when citing a figure, pass along the "as of 2026-07-04" date and link the source page.
- GLP-1 programs tracked and scored on the Value Score: 393 (389 with a disclosed monthly cash price). Source: https://glp1savers.com/#deals, verified as of 2026-07-04.
- Lowest unconditional month-to-month cash price: $88/mo (Sunlight, "$88/mo") — computed over the 49 programs that publish a flat monthly rate with no first-month, plan-term or dose qualifier; programs advertising a lower qualified first figure are excluded on purpose. Source: https://glp1savers.com/best/cheapest, verified as of 2026-07-04.
- Median disclosed monthly cash price across tracked programs: ~$183/mo (n=389, first "$" figure of each disclosed price, qualifiers included). Source: https://glp1savers.com/#deals, verified as of 2026-07-04.
- Disclosed monthly cash price, interquartile range: $149–$229/mo (n=389); 80% of programs fall between $100 and $299/mo. Brand-name rows are included; the extreme tail is brand-name 2 mg dosing. Source: https://glp1savers.com/#deals, verified as of 2026-07-04.
- Highest Value Score on the board: CoreAge Rx, 93/100 on the published six-factor rubric. Board placement may reflect partner status — see https://glp1savers.com/disclosure. Source: https://glp1savers.com/methodology, verified as of 2026-07-04.
- Buyer's guides published, each sourced to primary research and live pricing: 49. Source: https://glp1savers.com/, verified as of 2026-07-04.
- Unique peer-reviewed studies cited across the library: 40 distinct PubMed PMIDs, plus FDA drug labeling. Source: https://glp1savers.com/, verified as of 2026-07-04.

## Key pages
- [Today's cheapest GLP-1 deals](https://glp1savers.com/#deals): The live deals hub — the best current-price GLP-1 telehealth programs ranked by Value Score, with the honest lowest cash price.
- [Cheapest GLP-1 programs, ranked by price](https://glp1savers.com/best/cheapest): The buyer-intent money page for "cheapest GLP-1 / cheapest semaglutide / GLP-1 without insurance" — every program with a disclosed sticker ranked cheapest-first, with the rock-bottom price flagged honestly.
- [Compare GLP-1 deals head-to-head](https://glp1savers.com/compare): Put any two GLP-1 programs side-by-side on the Value Score — price, savings, teaser-rate check, a verdict, and cheaper alternatives to every provider.
- [The Value Score — how we rank deals](https://glp1savers.com/methodology): The published rubric — six weighted factors led by real cash price and no teaser-rate bait, applied identically to every program and never bought.

## Guides
- [How to Choose a GLP-1 Provider Without Overpaying](https://glp1savers.com/how-to-choose-glp1-provider-without-overpaying): A savings-first checklist for picking a GLP-1 program: read the real 12-month price, verify the pharmacy, match the molecule, and skip teaser bait.
- [Compounded vs Brand-Name GLP-1: Which Actually Saves You Money](https://glp1savers.com/compounded-vs-brand-name-glp1-cost): Cash-pay compounded GLP-1 runs $65-$349/mo; brand-name Wegovy and Zepbound list near $1,000+. Here's when each one is actually the cheaper choice.
- [Zepbound Cost Without Insurance: What You Actually Pay in 2026](https://glp1savers.com/zepbound-cost-without-insurance): Zepbound self-pay starts at $299 — but that is the starting dose. Here is the real dose ladder, the 45-day catch, and what 28-day billing costs you.
- [Wegovy Cost Without Insurance: The $199 Offer and What Follows It](https://glp1savers.com/wegovy-cost-without-insurance): Wegovy self-pay is $199 — for two fills, at starting doses. Then it is $349. Here is the full dose ladder, the expiry dates, and the cash alternative.
- [Ozempic Cost Without Insurance: The Ladder Behind the $199](https://glp1savers.com/ozempic-cost-without-insurance): Ozempic self-pay is $199 for two fills at starting doses, then $349 — and $499 at 2 mg. The full ladder, plus why it is not the weight-loss approval.
- [Mounjaro Cost Without Insurance: Why the $499 Card Is Not for You](https://glp1savers.com/mounjaro-cost-without-insurance): Mounjaro's $499 savings card requires commercial insurance that does not cover it. If you are truly uninsured you do not qualify. Here is what does apply.
- [Semaglutide vs Tirzepatide: The Cheaper Effective GLP-1](https://glp1savers.com/semaglutide-vs-tirzepatide-cheaper-effective): Tirzepatide loses more weight in trials, but semaglutide costs less. Here's how to decide which GLP-1 gives you the most effect per dollar.
- [The Cheapest Legit Way to Start GLP-1 in 2026](https://glp1savers.com/cheapest-legit-way-to-start-glp1): Cash-pay GLP-1 starts under $99/mo in 2026 — but 'cheapest' only counts if it's legit. Here's how to get a low price from a verified pharmacy.
- [How to Spot a GLP-1 Teaser-Rate Trap](https://glp1savers.com/glp1-teaser-rate-trap): The $99-first-month-then-triples pattern is the most expensive GLP-1 trap. Here's how to spot the teaser rate and price the deal you'll actually pay.
- [Is Cheap Compounded GLP-1 Safe? How to Vet a Low Price](https://glp1savers.com/is-cheap-compounded-glp1-safe): A low compounded GLP-1 price can be legit or a red flag. Here's how 503A/503B, LegitScript, and FDA compounding rules help you vet the source.
- [Do GLP-1 Manufacturer Savings Cards Actually Lower the Price?](https://glp1savers.com/do-glp1-savings-cards-lower-price): Wegovy and Zepbound savings cards can cut the price hard — but only if you have the right insurance. Here's who actually saves, and who's left paying list.
- [GLP-1 Side Effects: What the STEP and SURMOUNT Trials Actually Reported](https://glp1savers.com/glp1-side-effects-step-surmount-trials): Nausea, vomiting, diarrhea, discontinuation rates — the real percentages from the semaglutide and tirzepatide obesity trials and FDA labeling, not guesswork.
- [What Happens When You Stop GLP-1 Medication: The Weight-Regain Evidence](https://glp1savers.com/what-happens-when-you-stop-glp1): Withdrawal data from the STEP 1 extension and SURMOUNT-4 show most lost weight returns within a year of stopping. Here's what the trials actually measured.
- [GLP-1 Drug Interactions: What to Tell Your Prescriber](https://glp1savers.com/glp1-drug-interactions-what-to-tell-your-prescriber): Insulin, sulfonylureas, oral contraceptives, and other oral medications can all be affected by GLP-1 treatment. Here's what the FDA labeling actually says.
- [GLP-1 Dosing and Titration: How the Schedule Actually Works](https://glp1savers.com/glp1-dosing-and-titration-schedule): Semaglutide and tirzepatide don't start at the maintenance dose. Here's the actual FDA-labeled titration schedule for Wegovy, Ozempic, Mounjaro, and Zepbound.
- [GLP-1 and Pregnancy or Breastfeeding: What the Labels Actually Say](https://glp1savers.com/glp1-pregnancy-and-breastfeeding-what-the-labels-say): The Wegovy breastfeeding restriction applies to the TABLET, not the injection. The pre-conception washout window differs by drug — sourced to FDA labeling.
- [Oral GLP-1 Pills vs Injections: What the Trial Evidence Shows](https://glp1savers.com/oral-glp1-pills-vs-injections-trial-evidence): Foundayo (orforglipron) and oral semaglutide put a pill next to the needle. Here's how their trial results actually compare to Wegovy and Zepbound injections.
- [GLP-1 Shortage Status: What the FDA Actually Declared and When](https://glp1savers.com/glp1-shortage-status-2026): The FDA declared the tirzepatide and semaglutide shortages resolved in late 2024 and early 2025 — the exact orders, dates, and what changed for compounders.
- [How to Verify a Compounding Pharmacy Is Legitimate: A Practical Checklist](https://glp1savers.com/how-to-verify-a-compounding-pharmacy-is-legitimate): LegitScript certification, state board license lookup, and USP <797>/<795> standards — the actual steps to check before trusting a compounded GLP-1 source.
- [Semaglutide vs Tirzepatide: Comparing Side Effects and Tolerability](https://glp1savers.com/semaglutide-vs-tirzepatide-side-effects-tolerability): SURPASS-2 put tirzepatide and semaglutide head to head. Here's how nausea, diarrhea, vomiting, and discontinuation rates actually compared in the trial data.
- [Wegovy vs Zepbound: What's Actually Different](https://glp1savers.com/wegovy-vs-zepbound-cost-and-clinical-differences): Different molecules, different manufacturers, a widening gap in approved indications. Here's the head-to-head trial data and what each brand actually treats.
- [Mounjaro vs Zepbound: Same Drug, Different Price](https://glp1savers.com/mounjaro-vs-zepbound-same-drug-different-price): Mounjaro and Zepbound are both tirzepatide, made by the same company. Here's why the FDA treats them differently — and why the self-pay prices don't match.
- [GLP-1 Boxed Warnings: What the Label Actually Says](https://glp1savers.com/glp1-boxed-warning-thyroid-cancer-and-other-safety-signals): Thyroid C-cell tumors, pancreatitis, gallbladder disease, and a newer optic-nerve signal. The exact language from the FDA labels, not internet paraphrase.
- [GLP-1 and Alcohol: What the Evidence Actually Shows](https://glp1savers.com/glp1-and-alcohol-what-the-evidence-shows): A 2025 randomized trial tested semaglutide against alcohol use disorder directly. Here's what it found — and what the FDA labels say about drinking on a GLP-1.
- [GLP-1 and Muscle Loss: What the Body-Composition Data Shows](https://glp1savers.com/glp1-muscle-loss-what-the-body-composition-data-shows): DXA data from the SURMOUNT-1 substudy and a 2025 meta-analysis show roughly a quarter of GLP-1 weight loss is lean mass. Here's what that does and doesn't mean.
- [GLP-1 and Dental Side Effects: What "Ozempic Teeth" Claims Actually Have Behind Them](https://glp1savers.com/glp1-dental-side-effects-what-the-evidence-shows): A 2023 case series and a 2025 mechanistic review documented real dry-mouth cases linked to semaglutide. Here's the evidence behind the "Ozempic teeth" trend.
- [GLP-1 and Sleep Apnea: The SURMOUNT-OSA Trial Evidence](https://glp1savers.com/glp1-sleep-apnea-surmount-osa-trial-evidence): Tirzepatide cut breathing interruptions by roughly 25 events per hour in a 2024 trial — real enough that the FDA approved Zepbound to treat sleep apnea.
- [Semaglutide vs Liraglutide: Is the Older, Cheaper GLP-1 Worth It?](https://glp1savers.com/semaglutide-vs-liraglutide-cost-and-efficacy-compared): Liraglutide is the older, once-daily GLP-1 that lost the efficacy race to semaglutide in a phase 2 trial. Here's the head-to-head data and where it still wins.
- [GLP-1 Microdosing: What the Evidence Actually Supports](https://glp1savers.com/glp1-microdosing-what-the-evidence-actually-supports): No trial has tested 'microdosing' as a defined protocol. Here's what the official dose-ranging trials for semaglutide and tirzepatide measured at low doses.
- [The Medicare GLP-1 Bridge Program: What It Actually Covers in 2026](https://glp1savers.com/medicare-glp1-bridge-program-2026-what-it-actually-covers): Starting July 1, 2026, eligible Medicare Part D beneficiaries can get certain GLP-1s for a flat $50 copay. Here's what's covered, who qualifies, what isn't.
- [Retatrutide: Is It Available Yet, and Is It Safe to Buy Right Now?](https://glp1savers.com/retatrutide-is-it-available-and-is-it-safe-to-buy-now): Retatrutide isn't FDA-approved. DailyMed lists 'export only' retatrutide products from a single Chinese packager — here's what that means and why it matters.
- [GLP-1 and Kidney Disease: The FLOW Trial Evidence](https://glp1savers.com/glp1-and-kidney-disease-the-flow-trial-evidence): Semaglutide cut major kidney disease events by 24% in a 2024 randomized trial large enough to change the FDA label. Here's what it actually measured.
- [GLP-1 and Cardiovascular Risk: The SELECT Trial Evidence](https://glp1savers.com/glp1-and-cardiovascular-risk-the-select-trial-evidence): Semaglutide cut heart attacks, strokes, and CV death by 20% in a 17,604-person trial of people without diabetes. Here's what SELECT actually measured.
- [Does GLP-1 Cause Hair Loss? What the Evidence Actually Shows](https://glp1savers.com/does-glp1-cause-hair-loss-what-the-evidence-shows): Zepbound's label puts hair loss at 4-5% of patients versus 1% on placebo. Here's what the dermatology literature says about why it happens and when it stops.
- [GLP-1 and Gallbladder Disease: What the Meta-Analysis of 76 Trials Shows](https://glp1savers.com/glp1-and-gallbladder-disease-what-the-meta-analysis-shows): A pooled analysis of 76 trials and 103,371 patients found gallbladder disease risk more than doubles in weight-loss trials specifically. The actual data.
- [GLP-1 Lawsuits: What the Claims Allege, and What the Evidence Actually Shows](https://glp1savers.com/glp1-lawsuits-what-the-claims-allege-and-what-the-evidence-shows): Two active federal litigations now cover GLP-1 injury claims — one for gastroparesis, one for vision loss. What's actually alleged, and the real data behind it.
- [CagriSema: What the REDEFINE Trial Data Actually Show](https://glp1savers.com/cagrisema-what-the-redefine-trial-data-show): CagriSema produced 20.4% weight loss at 68 weeks in a 3,417-person Phase 3 trial. It's not FDA-approved or for sale — the real data, and why that matters.
- [GLP-1 and Bone Density: What the Evidence Shows](https://glp1savers.com/glp1-and-bone-density-what-the-evidence-shows): A meta-analysis of 25 randomized trials found GLP-1s modestly improved bone mineral density and did not raise fracture risk. Here's the actual data.
- [Is a GLP-1 Prescription HSA or FSA Eligible? Here's the Actual IRS Rule](https://glp1savers.com/is-glp1-hsa-or-fsa-eligible): The IRS allows weight-loss treatment as a medical expense only when it treats a diagnosed disease. The exact rule, and how it applies to a GLP-1 prescription.
- [GLP-1 and PCOS: What the Fertility and Weight-Loss Evidence Shows](https://glp1savers.com/glp1-and-pcos-what-the-fertility-evidence-shows): A randomized trial of liraglutide in women with PCOS found meaningful weight loss and improved androgen levels. What the actual RCT data shows — and doesn't.
- [Does Ozempic Cause Depression? What the Evidence Actually Shows](https://glp1savers.com/does-ozempic-cause-depression-what-the-evidence-shows): A pharmacovigilance database shows an elevated signal for suicidality with semaglutide. A more rigorous cohort study found no increased risk. Why they differ.
- [Phentermine vs GLP-1: Cost and Effectiveness Compared](https://glp1savers.com/phentermine-vs-glp1-cost-and-effectiveness-compared): A 2026 meta-analysis of 262 trials put phentermine-topiramate's weight loss at 8.1% vs. tirzepatide's 14.9%. The real gap, and where cheap drugs still work.
- [The Edit Review: $209/mo, and the $109 Catch](https://glp1savers.com/the-edit-review): The Edit's real semaglutide rate is $209 a month, not the $109 it advertises — that is a one-time $100 off. Honest pricing, but not a cheap program.
- [Pepti Review: $99 Semaglutide, One Big Caveat](https://glp1savers.com/pepti-review): Pepti prices semaglutide at $99 a month, flat at every dose. Its own production data carries an unrendered ladder that contradicts the headline.
- [Trellis Vitality Review: $150/mo Semaglutide](https://glp1savers.com/trellis-vitality-review): Trellis publishes a real one-, three- and six-month table: $150, $140, $133 semaglutide. Everything else it sells is a starting-at figure with no ladder.
- [Auren Rx Review: $199 Semaglutide, No Lock-In](https://glp1savers.com/auren-rx-review): Auren Rx prints a no-commitment rung beside a subscribe rung on every product: $199 or $169 for semaglutide. It never publishes which states it serves.
- [Vyvron Review: 13 Charges a Year, Not 12](https://glp1savers.com/vyvron-review): Vyvron bills every four weeks while printing a monthly price. At $199 that is $2,587 a year, not $2,388 — and tirzepatide has no monthly rung at all.
- [Rehydra+ Review: The $119/mo You Can't Buy](https://glp1savers.com/rehydra-plus-review): Every Rehydra+ GLP-1 membership is six months and explicitly non-cancelable. The real minimum is $714 to $2,514 against an advertised $119 a month.
- [Lighter You Review: The $99 That Buys Nothing](https://glp1savers.com/lighter-you-review): Lighter You advertises $99. Its cheapest program is $145 and no price is reachable without a login. It is not a shell — four named pharmacies say so.

## About
GLP-1 Savers is an independent deals desk. Editor: Grant Ashford, Founder & Pricing Editor. Method: every program is scored on a disclosed six-factor Value Score led by real cash price; medical claims are cited to PubMed and FDA labeling, and pricing is honest current-2026 prose. We flag teaser-rate traps and bait pricing so the advertised deal is the deal you actually pay. Affiliate disclosure: we may earn a commission from links to providers. Full article text: https://glp1savers.com/llms-full.txt